ANAB
AnaptysBio Inc
51.00$
-1.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +10.9% | -5.0% | -40.1% | -50.0% | +60.0% | +837.5% | -15.8% | -83.7% | +66.8% | +432.0% | +157.0% | |
| – | +100.9% | -10.9% | +91.0% | +90.9% | +76.8% | -19.4% | +23.1% | -9.8% | +49.0% | +23.9% | -98.5% | |
| – | -96.3% | +373.8% | -1,637.0% | – | – | – | – | – | – | – | – | |
| – | +100.9% | +30.7% | +36.8% | +81.9% | +76.5% | -19.4% | +23.1% | -9.8% | +57.2% | +17.3% | -17.0% | |
| – | +52.5% | +19.5% | +117.7% | +66.3% | +3.7% | +17.1% | +14.0% | +70.5% | +14.5% | +1.1% | +19.7% | |
| – | +52.5% | +19.5% | +117.7% | +66.3% | +3.7% | +17.1% | +14.0% | +70.5% | +34.5% | -14.0% | +334.7% | |
| – | -168.2% | – | – | – | – | – | – | – | – | – | – | |
| – | -64.1% | -0.4% | +287.6% | -6.9% | -37.0% | +280.3% | -63.4% | +1,355.7% | -14.3% | +177.0% | +59.5% | |
| – | -249.1% | – | – | – | – | – | – | – | – | – | – | |
| – | -89.2% | +47.5% | +788.3% | -110.5% | – | – | – | – | -116.7% | – | +5,366.7% | |
| – | -2,429.7% | – | – | – | – | – | – | – | – | – | – | |
| – | -188.5% | – | – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.